Lin Y-C, Chang Y-H, Yang S-Y, Wu K-D, Chu T-S. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc. 2018;117:662–75. https://doi.org/10.1016/j.jfma.2018.02.007.

Article  CAS  PubMed  Google Scholar 

Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248–60. https://doi.org/10.1016/j.kint.2022.05.012.

Article  CAS  PubMed  Google Scholar 

Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacology. 2015;5:49–56.

Google Scholar 

Noubiap JJN, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: A systematic review. World J Diabetes. 2015;6:759–73. https://doi.org/10.4239/wjd.v6.i5.759.

Article  PubMed  PubMed Central  Google Scholar 

Djrolo F, Attolou VG, Avode DG, Houngbe F, Akpona S, Addra B, et al. Diabetic nephropathy: an epidemiological study based on proteinuria in a population of black African diabetics in Cotonou, Benin. Sante Montrouge Fr. 2001;11:105–9.

CAS  Google Scholar 

García-Carro C, Vergara A, Bermejo S, Azancot MA, Sánchez-Fructuoso AI, Sánchez de la Nieta MD, et al. How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR. J Clin Med. 2021;10:2505. https://doi.org/10.3390/jcm10112505.

Article  PubMed  PubMed Central  Google Scholar 

Rico-Fontalvo J, Aroca-Martínez G, Daza-Arnedo R, Cabrales J, Rodríguez-Yanez T, Cardona-Blanco M, et al. Novel Biomarkers of Diabetic Kidney Disease. Biomolecules. 2023;13:633. https://doi.org/10.3390/biom13040633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021;18:14791641211058856. https://doi.org/10.1177/14791641211058856.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mottl AK, Kwon K-S, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications. 2013;27:123–7. https://doi.org/10.1016/j.jdiacomp.2012.09.010.

Article  PubMed  Google Scholar 

MacIsaac RJ, Ekinci EI, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria?: contra. Kidney Int. 2014;86:50–7. https://doi.org/10.1038/ki.2014.98.

Article  PubMed  Google Scholar 

Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease. Diabetologia. 2018;61:996–1011. https://doi.org/10.1007/s00125-018-4567-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coca SG, Nadkarni GN, Huang Y, Moledina DG, Rao V, Zhang J, et al. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease. J Am Soc Nephrol JASN. 2017;28:2786–93. https://doi.org/10.1681/ASN.2016101101.

Article  CAS  PubMed  Google Scholar 

Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int. 2015;87:812–9. https://doi.org/10.1038/ki.2014.330.

Article  CAS  PubMed  Google Scholar 

Niewczas MA, Pavkov ME, Skupien J, Smiles A, Md Dom ZI, Wilson JM, et al. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat Med. 2019;25:805–13. https://doi.org/10.1038/s41591-019-0415-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, et al. Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes. J Am Soc Nephrol JASN. 2014;25:2177–86. https://doi.org/10.1681/ASN.2013070758.

Article  CAS  PubMed  Google Scholar 

Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008;1:200–8. https://doi.org/10.1111/j.1752-8062.2008.00053.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voorhis C, Morgan B. Understanding Power and Rules of Thumb for Determining Sample Sizes. Tutor Quant Methods Psychol. 2007;3(2):43–50. https://doi.org/10.20982/tqmp.03.2.p043.

Article  Google Scholar 

Alberti KGMM, Zimmet PZ, Consultation WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med. 1998;15:539–53.

Article  CAS  PubMed  Google Scholar 

American Diabetes Association. 11 Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020. Diabetes Care. 2020;43:S135-51. https://doi.org/10.2337/dc20-S011.

Article  Google Scholar 

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem. 1972;18:499–502. https://doi.org/10.1093/clinchem/18.6.499.

Article  CAS  PubMed  Google Scholar 

Barutta F, Bellini S, Canepa S, Durazzo M, Gruden G. Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Acta Diabetol. 2021;58:819–30. https://doi.org/10.1007/s00592-020-01656-9.

Article  PubMed  Google Scholar 

Zhang Z, Cai CX. Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway. Mol Cell Biochem. 2016;416:109–16. https://doi.org/10.1007/s11010-016-2700-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murakoshi M, Gohda T, Suzuki Y. Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease. Int J Mol Sci. 2020;21:1957. https://doi.org/10.3390/ijms21061957.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nauta FL, Boertien WE, Bakker SJL, van Goor H, van Oeveren W, de Jong PE, et al. Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes. Diabetes Care. 2011;34:975–81. https://doi.org/10.2337/dc10-1545.

Article  PubMed  PubMed Central  Google Scholar 

Waijer SW, Sen T, Arnott C, Neal B, Kosterink JGW, Mahaffey KW, et al. Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2022;17:251–9. https://doi.org/10.2215/CJN.08780621.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Z, Zhu Y, Sun X, Zhu H, Jiang W, Sun M, et al. Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study. Front Endocrinol. 2022;13:1064665. https://doi.org/10.3389/fendo.2022.1064665.

Article  Google Scholar 

Xu J, Lee ET, Devereux RB, Umans JG, Bella JN, Shara NM, et al. A Longitudinal Study of Risk Factors for Incident Albuminuria in Diabetic American Indians: The Strong Heart Study. Am J Kidney Dis. 2008;51:415–24. https://doi.org/10.1053/j.ajkd.2007.11.010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Jin D, Qiu H, Lin L, Sun S, Li D, et al. Assessment of urinary podocalyxin as an alternative marker for urinary albumin creatinine ratio in early stage of diabetic kidney disease in older patients. Nefrologia. 2022;42:664–70. https://doi.org/10.1016/j.nefro.2021.08.005.

Article  PubMed  Google Sch